Latest News

Stop alcohol concept. Person refuse to drink alcohol. | Image Credit: © Pormezz - stock.adobe.com
DemeRx’s Neuroplastogen Candidate Signals New Alcohol Use Disorder Approach

October 7th 2025

The awarded $1.7 million in funding will support the company’s preclinical and clinical progress on DMX-1001 (noribogaine), designed to reduce relapse and improve brain health in patients with alcohol use disorder.

Prescription medicine bottle and oral syringe for baby isolated on blue background | Image Credit: © nd700 - stock.adobe.com
Enhancing Patient-Centric Care Through Oral Liquid Drug Delivery Formulations

October 7th 2025

Glowing helicobacter pylori bacteria cells on dark blue background. Gastritis disease. 3d-rendering | Image Credit: © ecrow - stock.adobe.com
RedHill's $1.8M Middle East Deal Signals Global Demand for Effective H. pylori Treatment

October 6th 2025

Targeted Alpha Therapy as a cancer treatment in clinical trials as a oncology therapies targeting malignant tumors with radioactive particles destroying cells | Image Credit: ©freshidea -stock.adobe.com
Collaborating on the Development of Radiopharmaceuticals

October 6th 2025

Color 3d DNA molecule helix inear the lab test tube | Image Credit: © Елена Бутусова -stock.adobe.com
Enhancing Bioanalysis and Drug Development with Advanced Tools and Technologies

October 4th 2025

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Research into Cold Cancers Heating Up; Image: catalin - Stock.adobe.com
Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.